Zenotech has two heads and gets behind as Daiichi Sankyo watches on
This article was originally published in Scrip
Executive Summary
All is not settled at the Indian biotech firm, Zenotech Laboratories, with its founder complaining that two heads are not better than one, and lamenting that Daiichi Sankyo, now in effect a majority shareholder in the company, has not been sufficiently involved in running it. Industry analysts are now becoming concerned that intra-management carping at Zenotech is causing the company to lose ground on its rivals.